This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Net Medical Xpress Reports Positive 2012 Net Income On 22% Revenue Increase Driven By Rapid Telemedicine Customer Growth And Usage

ALBUQUERQUE, N.M., March 25. 2013 /PRNewswire/ -- Net Medical Xpress Solutions, Inc. (OTCQB: NMXS) announced today 2012 revenue of $3,905,000, a 21.8% gain over revenue of $3,207,000 in fiscal year 2011. The company also reported net income of $5,000, or $0.00 per share versus a net loss in 2011 of ($224,000) or $0.00 per share.

CEO Dick Govatski said, "We are delighted to be able to report positive net income in our most financially successful year ever. Telemedicine is the rising star of the health care industry and we find ourselves on a wave that we believe will carry us quite far.

"Our services ranging from remote patient examinations to critical care specialist programs and related telemedicine services are in increasingly high demand as a result of our growing capability to provide outstanding technology and programs to a marketplace anxiously looking to improve patient care while lowering costs. This has not gone unrecognized by the medical community and consequently our order books are filling up almost daily.

"Our gross profit was a key indicator of our 2012 success reaching 23.6% with some segments over 40%. We believe we will be able to improve this number in 2013.

"Bottom line -- we are in the right place at the right time. Our programs have expanded from teleradiology to more sophisticated telemedicine programs involving cardiology, neurology and even psychiatry. Remote hospitals benefit from being able to offer top-level care in disciplines they previously could not afford to provide. But now even larger hospital groups are becoming aware of the improvements and savings we can provide them.

"We expect 2013 is going to be an outstanding year for our company and our shareholders as we foresee ongoing growth in both customers and usage of our systems and programs.  Results for the first quarter of 2013 will be reported in mid-April. Current information suggests we will report a very successful quarter," Govatski said.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,689.86 -56.12 -0.32%
S&P 500 2,103.84 -4.79 -0.23%
NASDAQ 5,128.2810 -0.5040 -0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs